Orexin-A vs Plecanatide
Head-to-head comparison of Orexin-A (Hypocretin-1 (Orexin-A)) and Plecanatide (Plecanatide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Orexin-A | Plecanatide |
|---|---|---|
| Category | Cognitive Enhancement | Gastrointestinal |
| Full Name | Hypocretin-1 (Orexin-A) | Plecanatide |
| Molecular Weight | 3562 Da | Approx. 1620 Da |
| Half-Life | Minutes to <1 hour | Local intestinal action; systemic half-life not clinically meaningful |
| Amino Acids | 33 | 16 |
| Typical Dose | Research-only; no validated human dose | 3 mg once daily |
| Route | Intracerebroventricular/Intranasal | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 42 | 350 |
| Research Status | Pre-clinical | Clinical |
Orexin-A Benefits
- ✓wakefulness
- ✓attention
- ✓memory consolidation
- ✓fatigue resistance
Plecanatide Benefits
- ✓improves-stool-frequency
- ✓supports-fluid-secretion
- ✓may-reduce-constipation
- ✓local-gut-action
Orexin-A Dosing
Research-only i.c.v. microgram/nanomolar studies|intranasal experimental use|no established human protocol
Plecanatide Dosing
3 mg PO daily|take with or without food|avoid when dehydrated
Orexin-A Side Effects
- ⚠insomnia
- ⚠headache
- ⚠blood pressure changes
Plecanatide Side Effects
- ⚠diarrhea
- ⚠abdominal-discomfort
- ⚠nausea
Research Overview
Orexin-A
Preclinical studies link orexin signaling to arousal, learning, and memory consolidation, making orexin-A a candidate for cognition-related research. It is not an approved cognitive enhancer and remains an experimental peptide.
Plecanatide
Clinical trials show plecanatide improves constipation outcomes with a generally favorable tolerability profile. Like linaclotide, it acts locally in the intestinal lumen via GC-C signaling rather than systemic hormone effects.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.